Apriglim MV 1 Tablet SR
By Apriglim-MV
Rx
15 Tablet SR in a Strip

Composition
Glimepiride(1mg) + Metformin(500mg) + Voglibose(0.2mg)

Manufacturer - Aprica Pharmaceuticals Pvt Ltd
A/4 4th Floor, Safal Profitaire,Corporate Road,Nr Prahladnagar Garden, Prahladnagar,Ahmedabad- 380015, Gujarat, India.

Expires on or after
November, 2027

liver
Apriglim MV 1 Tablet SR should be used carefully in individuals with liver issues. It may be necessary to adjust the dosage of Apriglim MV 1 Tablet SR in such cases. It is advised to seek guidance from your healthcare provider before using this medication. Typically, Apriglim MV 1 Tablet SR is initiated at a low dose for patients with mild to moderate liver problems. However, it is not recommended for use in individuals with severe liver disease.

kidney
Apriglim MV 1 Tablet SR may not be safe for patients with kidney disease and is not recommended for those with severe kidney issues. Consult your doctor before use.

alcohol
It is unsafe to consume alcohol with Apriglim MV 1 Tablet SR. Avoid alcohol when taking this medication. Caution - Pregnancy It is important to consult your doctor regarding alcohol consumption with Apriglim MV 1 Tablet SR during pregnancy.

driving
To ensure safety, avoid driving if experiencing low or high blood sugar symptoms while taking Apriglim MV 1 Tablet SR.

pregnancy
Apriglim MV 1 Tablet SR may be harmful during pregnancy based on animal studies. Consult your doctor to assess potential risks and benefits before using it.

breastfeeding
Apriglim MV 1 Tablet SR is likely unsafe during breastfeeding. Limited data indicates it may pass into breastmilk and harm the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹247.67
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024